Page last updated: 2024-08-23

diaziquone and Lymphoma

diaziquone has been researched along with Lymphoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bedikian, AY; Bodey, GP; Cabanillas, F; McLaughlin, P1
Ettinger, LJ; Hammond, GD; Krailo, MD; Krivit, WA; Ru, N; Ruccione, KS1
Dicke, KA; Spitzer, G1

Reviews

1 review(s) available for diaziquone and Lymphoma

ArticleYear
Evaluation of the use of high-dose cytoreduction with autologous marrow rescue in various malignancies.
    Transplantation, 1986, Volume: 41, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Bone Marrow Diseases; Bone Marrow Transplantation; Breast Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Evaluation; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasms; Neuroblastoma; Transplantation, Autologous

1986

Trials

1 trial(s) available for diaziquone and Lymphoma

ArticleYear
A phase II study of diaziquone in children with recurrent or progressive solid tumors. Report from the Childrens Cancer Study Group.
    The American journal of pediatric hematology/oncology, 1990,Fall, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Bone Marrow Diseases; Child; Child, Preschool; Drug Evaluation; Humans; Infant; Lymphoma; Neoplasm Recurrence, Local; Neoplasms

1990

Other Studies

1 other study(ies) available for diaziquone and Lymphoma

ArticleYear
Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory lymphoma.
    Cancer treatment reports, 1983, Volume: 67, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Humans; Lymphoma; Male; Middle Aged

1983